Ministerial Decree determining a List of Drugs and Other Pharmaceutical Products which must Appear in all Pharmaceutical Points of Sale

Citation: Decree 14 of 2005
Date: 1 June 2005
Language: English
Type: Legislation

Rwanda

Ministerial Decree determining a List of Drugs and Other Pharmaceutical Products which must Appear in all Pharmaceutical Points of Sale

Decree 14 of 2005

Published in Official Gazette 11 on 1 June 2005
Assented to on 3 May 2005
Commenced on 31 July 2005
[This is the version of this document from 1 June 2005.]

The Minister of Health,Given the Constitution of June 4, 2003, as revised to date especially in its Articles 120(1), 121(1) and 201;Given of the Law n° 12/99 of 02/07/1999 of the pharmaceutical art, particularly in is articles 100 and 101;After consideration and adoption by the Cabinet in its meeting held on the 26^th January 2005DECREED:

Article one

Pharmaceutical point of sale means any premise where the pharmaceutical activity is limited to the preservation and retail distribution of some drugs and other pharmaceutical products and whose management is reserved to a nurse or a pharmacist assistant.

Article 2

Hereby established, in conformity with the list herewith attached to this decree, is a list of drugs and other pharmaceutical products which must appear in all pharmaceutical points of sale.

Article 3

Any pharmaceutical point of sale must be in possession of, and regularly, the products appearing on the aforementioned list.

Article 4

Each wholesale pharmaceutical establishment shall distribute, to the pharmaceutical point of sale, only the products appearing on that list.

Article 5

The inspectorate of pharmacies of the Ministry of Health is responsible for the application and enforcement of this decree.

Article 6

All previous provisions contrary to this decree are abrogated.

Article 7

This decree comes into force sixty days after its publication in the Official Gazette of the Republic of Rwanda.

Drugs and others pharmaceutical products which must appear in a pharmaceutical point of sale

N°	Pharmacological Groups	Propositions
1	Analgesics non-narcotics, antipyretics, Non-steroidal Anti-inflammatory	Except injectables
2	Antibiotics	Only sulfamethoxazole + Thrimethoprime (Cotrimozazole)
3	Anti-fungal medicines	Dermatological
4	Antiprotozoal medicines (Amibe, Trichomonas, Giardia and others cilias)	Oral forms of Imidazole derivated
5	Anthelminthics	Oral forms of Mebendazole, Thiabendazole, Albendazole, Piperazine, Levamisole,
6	Anti-malarial medicines	OralfForm of Quinine, Amodiaquine + Sulfadoxine-Pyrimethamine and other combined forms
7	Non-steroidal Antiallergics	Only Oral Forms
8	Antacids	Except H2antagoists, Inhibitors of pump of proton and Prostaglandine analogous
9	Anti-spasmodic medicines	Oral forms of Butyl Scopolamine and Phloroglucinol
10	Anti-anaemia medicines	Fer, Fer + Folic acid
11	Re-hydration	Only Oral re-hydration salts (ORS)
12	Antidotes	Only Charcoal activated
13	Vitamins	Oral forms
14	Ophthalmologic preparations	Tetracycline ophtalmological, Chloramphenicol eye drop
15	Laxatives	Oral forms and suppository
16	Dermatological medicines	Except Steroids
17	Anti-cough	Oral forms
18	Condoms	Masculine and feminine
19	Treated Mosquito net	All forms
20	Medical Materials	For dressing and bandage, injectables

▲ To the top

History of this document

31 July 2005

Commenced

01 June 2005 this version

Published in Official Gazette 11

03 May 2005

Assented to